Genesis, mechanism, and avoidance of cosmetic coating defects - An industrial case study

Copyright © 2024 Elsevier B.V. All rights reserved..

Film-coated tablets as solid oral dosage forms are a well-accepted way of administering drugs but are not without specific challenges during manufacturing. One relevant criterion of the final product is the visual integrity and therewith, the absence of cosmetic optical defects such as edge chipping. The aim of the present study was to examine the origin of those edge chipping defects, which were observed during commercial manufacturing of film-coated tablets, and to provide recommendations for process optimization to reduce the defect occurrence. The unraveling of the herein described phenomenon necessitated an interplay of in-depth material characterization, discrete element modeling (DEM) as well as an in-house developed optical measurement system for the automated quantification of tablet defects. As a result of this investigation, the automatic unloading step after the tablet coating process was identified as the most critical step for the occurrence of chipping defects and a replacement by manual unloading was proposed to reduce the defect propensity. The recommended optimization was subsequently confirmed in several manufacturing runs and a reduction of defect propensity by a factor of 5 was observed, highlighting the relevance and the impact of the performed thorough investigation.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:655

Enthalten in:

International journal of pharmaceutics - 655(2024) vom: 25. Apr., Seite 124008

Sprache:

Englisch

Beteiligte Personen:

Flügel, Karsten [VerfasserIn]
Wiedey, Raphael [VerfasserIn]
Riehl, Carolin [VerfasserIn]
Kaminski, Ingo [VerfasserIn]
Riehl, Markus [VerfasserIn]

Links:

Volltext

Themen:

Automated picture analysis
Coating defects
Discrete element method
Industrial manufacturing of pharmaceutics
Journal Article
Material characterization
Tablets

Anmerkungen:

Date Completed 15.04.2024

Date Revised 15.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijpharm.2024.124008

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369835204